Yixintang Pharmaceutical (SZ:002727) Sou Hu Cai Jing·2025-11-08 06:27Core Viewpoint - Yixin Tang Pharmaceutical Group Co., Ltd. announced a share transfer plan by its controlling shareholder and chairman, Ruan Hongxian, to his daughters, which will not affect the company's control or governance structure [1][4]. Group 1: Share Transfer Details - Ruan Hongxian plans to transfer up to 5.856 million shares (1% of total share capital) to each of his daughters, Ruan Shengxiang and Ruan Aixiang, through block trading within three months after the announcement [1][4]. - The share transfer is characterized as a family internal transfer, and Ruan Hongxian will sign a "consensus action agreement" with his daughters post-transfer [1]. Group 2: Company Background - As of November 6, Yixin Tang's total market value was 7.865 billion yuan, making the shares transferred to Ruan Hongxian's daughters worth over 78 million yuan [4]. - Yixin Tang was established on November 8, 2000, and as of September 30, 2025, it operates 11,230 direct chain stores, serving 210 million customers annually across 10 provinces and municipalities in China [4]. Group 3: Personal Background of Shareholders - Ruan Hongxian, aged 59, held 31.74% of Yixin Tang's shares before the transfer [4]. - Ruan Shengxiang serves as the vice chairman of Shengai Traditional Chinese Medicine Group, while Ruan Aixiang was appointed as vice president of Yixin Tang in July this year [6][8].